Stem cell myths.

Standard

Stem cell myths. / Magnus, Tim; Liu, Ying; Parker, Graham C; Rao, Mahendra S.

in: PHILOS T R SOC B, Jahrgang 363, Nr. 1489, 1489, 2008, S. 9-22.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

Magnus, T, Liu, Y, Parker, GC & Rao, MS 2008, 'Stem cell myths.', PHILOS T R SOC B, Jg. 363, Nr. 1489, 1489, S. 9-22. <http://www.ncbi.nlm.nih.gov/pubmed/17284414?dopt=Citation>

APA

Magnus, T., Liu, Y., Parker, G. C., & Rao, M. S. (2008). Stem cell myths. PHILOS T R SOC B, 363(1489), 9-22. [1489]. http://www.ncbi.nlm.nih.gov/pubmed/17284414?dopt=Citation

Vancouver

Magnus T, Liu Y, Parker GC, Rao MS. Stem cell myths. PHILOS T R SOC B. 2008;363(1489):9-22. 1489.

Bibtex

@article{0fac3ad062a44ff8aaeb14970006a807,
title = "Stem cell myths.",
abstract = "Stem cells, although difficult to define, hold great promise as tools for understanding development and as therapeutic agents. However, as with any new field, uncritical enthusiasm can outstrip reality. In this review, we have listed nine common myths that we believe affect our approach to evaluating stem cells for therapy. We suggest that careful consideration needs to be given to each of these issues when evaluating a particular cell for its use in therapy. Data need to be collected and reported for failed as well as successful experiments and a rigorous scientific approach taken to evaluate the undeniable promise of stem cell biology.",
author = "Tim Magnus and Ying Liu and Parker, {Graham C} and Rao, {Mahendra S}",
year = "2008",
language = "Deutsch",
volume = "363",
pages = "9--22",
journal = "PHILOS T R SOC B",
issn = "0962-8436",
publisher = "Royal Society of London",
number = "1489",

}

RIS

TY - JOUR

T1 - Stem cell myths.

AU - Magnus, Tim

AU - Liu, Ying

AU - Parker, Graham C

AU - Rao, Mahendra S

PY - 2008

Y1 - 2008

N2 - Stem cells, although difficult to define, hold great promise as tools for understanding development and as therapeutic agents. However, as with any new field, uncritical enthusiasm can outstrip reality. In this review, we have listed nine common myths that we believe affect our approach to evaluating stem cells for therapy. We suggest that careful consideration needs to be given to each of these issues when evaluating a particular cell for its use in therapy. Data need to be collected and reported for failed as well as successful experiments and a rigorous scientific approach taken to evaluate the undeniable promise of stem cell biology.

AB - Stem cells, although difficult to define, hold great promise as tools for understanding development and as therapeutic agents. However, as with any new field, uncritical enthusiasm can outstrip reality. In this review, we have listed nine common myths that we believe affect our approach to evaluating stem cells for therapy. We suggest that careful consideration needs to be given to each of these issues when evaluating a particular cell for its use in therapy. Data need to be collected and reported for failed as well as successful experiments and a rigorous scientific approach taken to evaluate the undeniable promise of stem cell biology.

M3 - SCORING: Zeitschriftenaufsatz

VL - 363

SP - 9

EP - 22

JO - PHILOS T R SOC B

JF - PHILOS T R SOC B

SN - 0962-8436

IS - 1489

M1 - 1489

ER -